Editorial: Developing next-generation therapeutics to defeat mutation-driven cancer

By sjmartinez • October 11, 2024

Chow F, Lamoureux F, Moriceau G. Editorial: Developing next-generation therapeutics to defeat mutation-driven cancer. Front Immunol. 2024 Sep 26;15:1487952. doi: 10.3389/fimmu.2024.1487952. PMID: 39391312; PMCID: PMC11464455.

Tags: ADC, antibody drug conjugate, Cancer, combination therapy, Dermatology, Drug resistance, immunotherapy, next generation therapeutics, Publications, targeted therapy

Novel Taxol-Derivative, STO-1, Induces Selective Anti-Tumor Immunity and Sustained Remission of Glioblastoma Without Triggering Autoimmune Reactions

Mohapatra S, Guerrero A, Rahman N, Zaman KT, Wu J, Onyeagba C, Hu C, Pellegrini M, Vankudoth J, Kitamura S, O'Donnell L, Wadghiri YZ, Banerjee[...]

Library Preparation for Genome-Wide DNA Methylation Profiling

Hsu FM, Pellegrini M, Chen PY. Library Preparation for Genome-Wide DNA Methylation Profiling. Bio Protoc. 2025 Nov 5;15(21):e5488. doi: 10.21769/BioProtoc.5488. PMID: 41220974; PMCID: PMC12602117.

Cutaneous metastases of alveolar rhabdomyosarcoma in a young adult

Yan MJ, Wongvibulsin S, McKenzie S, Smart CN, Nguyen MO. Cutaneous metastases of alveolar rhabdomyosarcoma in a young adult. JAAD Case Rep. 2025 Sep 26;66:23-25.[...]